BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 27057627)

  • 21. Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination.
    Kimura M; Tojo T; Naito H; Nagata Y; Kawai N; Taniguchi S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):568-71. PubMed ID: 20093263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of primary tumor resection on the survival of patients with stage IV extrathoracic metastatic non-small cell lung cancer: A population-based study.
    Sun Z; Sui X; Yang F; Wang J
    Lung Cancer; 2019 Mar; 129():98-106. PubMed ID: 30545693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current readings: the most influential and recent studies regarding resection of lung cancer in m1a disease.
    Mordant P; Rivera C; Legras A; Le Pimpec Barthes F; Riquet M
    Semin Thorac Cardiovasc Surg; 2013; 25(3):251-5. PubMed ID: 24331148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease?
    Dai C; Ren Y; Xie D; Zheng H; She Y; Fei K; Jiang G; Chen C
    J Thorac Oncol; 2016 Oct; 11(10):1745-54. PubMed ID: 27567989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
    Zell JA; Ou SH; Ziogas A; Anton-Culver H
    Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Important prognostic factors for survival in patients with malignant pleural effusion.
    Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
    BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively.
    Hu J; Chen Y; Zhu X; Ma Q; Zhang J; Jiang G; Zhang P
    BMC Cancer; 2021 Apr; 21(1):445. PubMed ID: 33888088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer.
    Lv X; Cao J; Dai X; Rusidanmu A
    Thorac Cancer; 2018 Aug; 9(8):1026-1031. PubMed ID: 29927089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer ≤2 cm.
    Cao J; Xu J; He Z; Yuan P; Huang S; Lv W; Hu J
    J Thorac Cardiovasc Surg; 2018 Aug; 156(2):796-805.e4. PubMed ID: 29716729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
    Wei S; Xie M; Tian J; Song X; Wu B; Liu L
    Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Survival of American Joint Committee on Cancer 8th Edition Staging Descriptors for Clinical M1a Non-Small Cell Lung Cancer.
    Kumar A; Xu B; Srinivasan D; Potter AL; Raman V; Lanuti M; Yang CJ; Auchincloss HG
    Chest; 2024 Mar; 165(3):725-737. PubMed ID: 37544427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
    Enatsu S; Yoshida J; Yokose T; Nishimura M; Nishiwaki Y; Shirakusa T; Nagai K
    Ann Thorac Surg; 2006 Jan; 81(1):298-304. PubMed ID: 16368385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients.
    Shen H; Cao Y; Li X; Tan Y; Chen J; Yang Z; Kong Y; Yuan Y
    Medicine (Baltimore); 2016 May; 95(21):e3800. PubMed ID: 27227958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical Intervention for Non-Small-Cell Lung Cancer Patients with Pleural Carcinomatosis: Results From the Japanese Lung Cancer Registry in 2004.
    Iida T; Shiba M; Yoshino I; Miyaoka E; Asamura H; Date H; Okumura M; Tada H; Nakanishi Y; Dosaka-Akita H; Kobayashi H; Takahashi K; Inoue M; Yokoi K;
    J Thorac Oncol; 2015 Jul; 10(7):1076-82. PubMed ID: 26134225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non-small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination.
    Liu B; Liu L; Hu M; Qian K; Li Y
    Thorac Cancer; 2016 Sep; 7(5):549-555. PubMed ID: 27766779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of thoracic tumor radiotherapy on survival in non-small-cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study.
    Li Q; Hu C; Su S; Ma Z; Geng Y; Hu Y; Jin H; Li H; Lu B
    Cancer Med; 2023 Jul; 12(14):14949-14959. PubMed ID: 37288833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.